ACS Nano

1. XU Y, Yan X, Zhang F, Li Q, et al
   Intranasal Delivery of HPV Therapeutic Vaccines for Enhanced Mucosal Immunization and Anti-Tumor Immunity.
   ACS Nano. 2025;19:30046-30059.
   

   >> Share

   
   

   
   Acta Biochim Biophys Sin (Shanghai)

2. LIU B, Zhang Y, Wang Q, Wang Q, et al
   CD40 ligation-induced ERK activation leads to enhanced radiosensitivity in cervical carcinoma cells via promoting autophagy.
   Acta Biochim Biophys Sin (Shanghai). 2024;57:1252-1259.
   

   >> Share

   
   

   
   Acta Clin Belg

3. CATO V, Davy K, Annelies L, An N, et al
   Evaluation of a heat protocol with the Allplex HPV HR assay on the fully automated Seegene STARlet platform for detection of human papillomaviruses.
   Acta Clin Belg. 2025;80:91-99.
   

   >> Share

   
   

   
   Afr Health Sci

4. HUANG S, Guo H, Yu T, Gu G, et al
   Clinical efficacy comparison of CO2 laser treatment and LEEP surgery for cervical intraepithelial neoplasia with high-risk HPV infection.
   Afr Health Sci. 2025;25:52-58.
   

   >> Share

   
   
5. ALI HAJI A, Ndaboine E, Likonda B, Ottoman O, et al
   Clinical profile and immediate outcomes of concurrent chemoradiation for cervical cancer at the Bugando medical centre in Mwanza, Tanzania.
   Afr Health Sci. 2025;25:218-226.
   

   >> Share

   
   
6. KISAKA E, Kabalimu T, Semali I, Mashalla Y, et al
   Factors influencing utilisation of cervical cancer screening services among HIV positive women attending care and treatment centres in Kinondoni municipality, Dar es Salaam, Tanzania.
   Afr Health Sci. 2024;24:32-40.
   

   >> Share

   
   

   
   Am J Cancer Res

7. GONG Y, Zhou G, Gu Y, Zhang M, et al
   Peptostreptococcus anaerobius promotes cervical cancer angiogenesis by upregulating SCD to activate ERK pathway.
   Am J Cancer Res. 2025;15:3236-3244.
   

   >> Share

   
   

   
   Am J Epidemiol

8. HOLFORD TR, Chen HS, Kane MJ, Krapcho M, et al
   Updated CP*Trends: an online tool to compare cohort and period trends across cancer sites.
   Am J Epidemiol. 2025;194:2144-2149.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

9. HAMMOND KL, Kopelman ZA, Winkler SS, Buchek MC, et al
   The art of cold knife conization: a demonstration of technique in live patients and a low-fidelity simulation model.
   Am J Obstet Gynecol. 2025;233:210-214.
   

   >> Share

   
   

   
   Analyst

10. ZOU X, Gu T, Li X, Deng L, et al
    PAM-free activation of CRISPR/Cas12a via semi-nested asymmetric RPA: highly specific detection of HPV16 dsDNA.
    Analyst. 2025;150:3891-3898.
    

    >> Share

    
    

    
    Asia Pac J Oncol Nurs

11. ZHANG Q, Chen F, Xiao Z, Li S, et al
    Self-perceived burden, fear of progression and psychological flexibility in cervical cancer survivors: A moderated network analysis.
    Asia Pac J Oncol Nurs. 2025;12:100762.
    

    >> Share

    
    

    
    Asian Pac J Cancer Prev

12. SOETOMO CT, Gunawan MFB, De Liyis BG, Dewi PE, et al
    Unveiling The Impact of Prophylactic Para-Aortic Lymph Nodes Irradiation in Cervical Cancer: Meta-Analysis of Randomized Controlled Trials.
    Asian Pac J Cancer Prev. 2025;26:3075-3084.
    

    >> Share

    
    
13. YOUSIF BJ, Abd Alwahab DH, Mohammed HA, Yasin YS, et al
    Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein.
    Asian Pac J Cancer Prev. 2025;26:3053-3064.
    

    >> Share

    
    
14. KLANGPRAPAN N, Rodpenpear N
    The Performance of Modified Swede Colposcopic Index to Predict High Grade Cervical Intraepithelial Neoplasia and Cervical Cancer in the Real Clinical Practice, an External Validation Study.
    Asian Pac J Cancer Prev. 2025;26:2947-2952.
    

    >> Share

    
    
15. SIREGAR TP, Wanandi SI, Darmiati S, Kusuma F, et al
    Development of a Predictive Model for Therapy Response in Advanced-Stage Cervical Cancer Using Apparent Diffusion Coefficient (ADC) Value and Quantitative T2 Tumor on MRI: Correlation with Survivin Expression.
    Asian Pac J Cancer Prev. 2025;26:2889-2897.
    

    >> Share

    
    
16. M ZT, Pantagada N, Konuku K, Ad NK, et al
    In Vitro Anticancer Activities of Senna singueana Leaf Extracts against HeLa Cell Lines.
    Asian Pac J Cancer Prev. 2025;26:2869-2877.
    

    >> Share

    
    
17. KHAN FZA, Mazhar SB, Itua I
    Knowledge, Attitudes and Practices of Cervical Cancer Screening among Women Attending Gynecology Clinics at Tertiary Care Hospitals in the Capital City of Pakistan: A Cross-Sectional Survey.
    Asian Pac J Cancer Prev. 2025;26:2819-2825.
    

    >> Share

    
    
18. SIBARANI CNR, Salima S, Suardi D, Adrianto N, et al
    Efficacy and Safety of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiotherapy Compared to Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2025;26:2793-2802.
    

    >> Share

    
    
19. YANUARINI TA, Mulyani S, Widyaningsih V
    Interventions to Improve the Uptake of Cervical Cancer Screening with Visual Inspection with Acetic Acid: A Scoping Review.
    Asian Pac J Cancer Prev. 2025;26:2755-2762.
    

    >> Share

    
    

    
    Biomater Res

20. LIU K, Zuo R, Wang Z, Chen G, et al
    IR808-ATIPA: A Dual-Function Agent for Enhanced Computed Tomography Imaging and Radiotherapy Sensitization in Cervical Cancer Treatment.
    Biomater Res. 2025;29:0222.
    

    >> Share

    
    

    
    BMC Cancer

21. ZHANG Z, Wu H, Huang Y, Wei Y, et al
    High SNHG expression may contribute to poor cervical cancer prognosis, based on systematic reviews and meta-analyses.
    BMC Cancer. 2025;25:1350.
    

    >> Share

    
    
22. MUSHUMBUSI A, Kaizilege G, Chibwe E, Ottoman O, et al
    Three-year survival outcomes following radical hysterectomy in early-stage cervical carcinoma: A study at Bugando medical centre, Mwanza, Tanzania.
    BMC Cancer. 2025;25:1343.
    

    >> Share

    
    
23. LI YX, Cao SY, Fan Y, Zhang YF, et al
    Survival outcomes in IIIC cervical cancer by treatment strategies: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1340.
    

    >> Share

    
    

    
    BMC Public Health

24. FANG J, Cheng Y, Liu Y, Yang Q, et al
    How delays in seeking medical care for cervical cancer patients are affected by their health-seeking behaviour: a qualitative study.
    BMC Public Health. 2025;25:2881.
    

    >> Share

    
    
25. ENDALE HT, Negash HK, Getnet M, Asefa T, et al
    Cervical cancer screening uptake in East Africa: a systematic review and meta-analysis of observational studies.
    BMC Public Health. 2025;25:2831.
    

    >> Share

    
    
26. LAW J, Jessiman-Perreault G, Machado AA, Xu L, et al
    Individual-level characteristics and geospatial factors associated with cervical cancer screening participation in Alberta, Canada: a population-based cross-sectional study.
    BMC Public Health. 2025;25:2790.
    

    >> Share

    
    

    
    BMC Womens Health

27. TSEKPETSE P, Salu S, Otoo DM, Dushime JF, et al
    Rural-urban disparities in cervical cancer screening uptake and its predictors among women aged 30-49 years in Ghana: a multivariate decomposition analysis.
    BMC Womens Health. 2025;25:396.
    

    >> Share

    
    

    
    Brachytherapy

28. KAZOBA F, Sauli E, Nyanza E, Amasi AI, et al
    Evaluation of variability in applicator position and organs at risk dose in fractionated intracavitary brachytherapy for cervical cancer.
    Brachytherapy. 2025 Aug 21:S1538-4721(25)00254.
    

    >> Share

    
    
29. KAJIKAWA T, Masui K, Sakai K, Takenaka T, et al
    A machine learning-based decision support tool for standardizing intracavitary versus interstitial brachytherapy technique selection in high-dose-rate cervical cancer.
    Brachytherapy. 2025 Aug 20:S1538-4721(25)00255.
    

    >> Share

    
    

    
    Bull Cancer

30. VUJIC G, Planinic P, Babic I, Skvorc M, et al
    Impact of preoperative conization on treatment outcomes in cervical cancer patients undergoing abdominal radical hysterectomy.
    Bull Cancer. 2025 Aug 14:S0007-4551(25)00345.
    

    >> Share

    
    

    
    Cancer Causes Control

31. CAMPSON A, Ernst K, Lewis K, Starr A, et al
    The role of community health workers (CHWs) in improving cervical cancer screening rates and access to treatment in underserved US populations: a scoping review.
    Cancer Causes Control. 2025 Aug 18. doi: 10.1007/s10552-025-02047.
    

    >> Share

    
    

    
    Cancer Genet

32. WANG Y, Li X, Lian X, Huang B, et al
    Genetic silencing of CDC6 via AAV2-Delivered shRNA as a novel cancer genetics-based therapy for cervical carcinoma.
    Cancer Genet. 2025;296-297:208-216.
    

    >> Share

    
    
33. CHAO WR, Lee MY, Lee YJ, Sheu GT, et al
    Profiling of HER2, KRAS, and PIK3CA mutations in uterine cervical neuroendocrine carcinoma and implications for oncogenic driver targeting therapy.
    Cancer Genet. 2025;296-297:9-14.
    

    >> Share

    
    

    
    Cancer Rep (Hoboken)

34. JIAO W, Liu S, Shi J, Yu M, et al
    Integrative Genomic and Functional Approaches Identify FUOM as a Key Driver and Therapeutic Target in Cervical Cancer.
    Cancer Rep (Hoboken). 2025;8:e70306.
    

    >> Share

    
    

    
    Clin Oncol (R Coll Radiol)

35. S AN
    Letter to the Editor Regarding the Article 'Feasibility Study of an Efficient Plan Pool Adaptive Radiotherapy Technology Based on Low-dose Computed Tomography for Cervical Cancer'.
    Clin Oncol (R Coll Radiol). 2025;46:103919.
    

    >> Share

    
    

    
    Clin Radiol

36. JIAN L, Wu N, Bi F, Li H, et al
    Prognosis risk stratification in patients with cervical adenocarcinoma after surgery: Development and validation of integrated biomarkers.
    Clin Radiol. 2025;88:107000.
    

    >> Share

    
    

    
    Diagn Microbiol Infect Dis

37. BEN JEMIA Z, Fehri E, Ardhaoui M, Jaballah-Gabteni A, et al
    The TP53 "rs 1042522'' Polymorphism and its association with precancerous cervical lesions progression among Tunisian women.
    Diagn Microbiol Infect Dis. 2025;113:116981.
    

    >> Share

    
    

    
    Discov Oncol

38. ZHAO F, Zhong H, You L, Du Y, et al
    PTK6 mediated immune signatures revealed by single cell transcriptomic and multi omics big data analysis in cervical cancer.
    Discov Oncol. 2025;16:1566.
    

    >> Share

    
    
39. FENG N, Liu L
    Research on the regulatory effects and mechanisms of YES1 on apoptosis and autophagy in cervical cancer cells.
    Discov Oncol. 2025;16:1555.
    

    >> Share

    
    

    
    East Mediterr Health J

40. SAEED NK, Alshaikh S, Al-Beltagi M
    Comparative study of pap smear and polymerase chain reaction tests for human papillomavirus screening in Bahrain.
    East Mediterr Health J. 2025;31:453-462.
    

    >> Share

    
    

    
    Ecotoxicol Environ Saf

41. NING L, Li X, Xu Y, Zhang Y, et al
    Development of a multi-indicator risk prediction model for cervical cancer associated with benzo[a]pyrene and nicotine exposure: A multi-omics study integrating toxicological analyses and molecular docking.
    Ecotoxicol Environ Saf. 2025;303:118895.
    

    >> Share

    
    

    
    Einstein (Sao Paulo)

42. CUSTODIO NG, Queiroz FR, Melo Neto AB, Cavalcante BM, et al
    Membrane transporter genes predict chemoradiotherapy response in patients with cervical cancer.
    Einstein (Sao Paulo). 2025;23:eAO1154.
    

    >> Share

    
    

    
    Eur J Cancer

43. ZHANG Y, Kang Q, Qu R
    Letter Re: Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study.
    Eur J Cancer. 2025;228:115742.
    

    >> Share

    
    

    
    Eur J Med Res

44. YUAN J, Xu N, Gong X, Ai J, et al
    Identification of neoantigen epitopes in cervical cancer by multi-omics analysis.
    Eur J Med Res. 2025;30:763.
    

    >> Share

    
    

    
    Eur J Obstet Gynecol Reprod Biol

45. GORNIAK K, Pacholczak-Madej R, Muzykiewicz K, Blecharz P, et al
    Integrating locoregional therapy with ongoing immunotherapy after oligoprogression in recurrent/metastatic cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114658.
    

    >> Share

    
    

    
    Eur J Oncol Nurs

46. WANG H, Zhang Y, Li X, Hou Y, et al
    Understanding experiences and improvement needs of Chinese cervical cancer patients with external beam radiotherapy and 3D brachytherapy: A qualitative study using persona-driven journey maps.
    Eur J Oncol Nurs. 2025;78:102943.
    

    >> Share

    
    

    
    Front Bioinform

47. AN X, Huang X, Yu Q, Tang Y, et al
    Bioinformatics analysis of lncRNA and mRNA differentially expressed in patients with cervical cancer.
    Front Bioinform. 2025;5:1605681.
    

    >> Share

    
    

    
    Front Immunol

48. EWAISHA R, Ruffin MT, Williams S, Chung Y, et al
    Serum profiling of the antibody response to HPV in women with or without abnormal cervical cytology undergoing cervical cancer screening.
    Front Immunol. 2025;16:1612761.
    

    >> Share

    
    

    
    Front Med (Lausanne)

49. PEREMIQUEL-TRILLAS P, Roura E, Rangel-Sarmiento V, Morey F, et al
    Building the foundations for an organized population-based cervical cancer screening program with primary HPV self-sampling in Catalonia, Spain: findings from a pilot implementation study.
    Front Med (Lausanne). 2025;12:1580665.
    

    >> Share

    
    

    
    Front Oncol

50. YANG C, Li M, Yi X, Wang L, et al
    Multiparametric MRI-based radiomics for preoperative prediction of parametrial invasion in early-stage cervical cancer.
    Front Oncol. 2025;15:1604749.
    

    >> Share

    
    

    
    Gynecol Oncol

51. GAILLARD S, Alvarez J, Zhang T, Wang H, et al
    A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancer.
    Gynecol Oncol. 2025;201:86-96.
    

    >> Share

    
    

    
    Gynecol Oncol Rep

52. FURUYA RL, Boak K, Mullen MM, Wang D, et al
    Real-world outcomes after pembrolizumab treatment for cervical cancer: Results from a university setting.
    Gynecol Oncol Rep. 2025;60:101921.
    

    >> Share

    
    

    
    Health Educ Behav

53. KWON SC, Kranick JA, Islam NS, Wyatt LC, et al
    Applying Social Marketing Principles for Community-Based Cancer Screening Programs: Two Case Studies.
    Health Educ Behav. 2025;52:382-391.
    

    >> Share

    
    

    
    Health Expect

54. COLLING AM, Saunders T, Creagh N, Ashfaq M, et al
    'Why Didn't I Get That Choice?': A Qualitative Exploration of How Cervical Screening Choices Are Understood and Experienced by Screen-Eligible People in Australia, Two Years After Self-Collection Became an Option for All.
    Health Expect. 2025;28:e70397.
    

    >> Share

    
    

    
    Indian J Med Res

55. CHANDRA S, Patel M, Shah K, Trivedi K, et al
    HPV-DNA testing from self-sampled menstrual blood using M-strip: A proof-of-concept study on feasibility & acceptance of a novel biosampling method.
    Indian J Med Res. 2025;161:532-539.
    

    >> Share

    
    

    
    Int J Biol Macromol

56. MURUGESAN B, Rathinavel T, Kumar RS, Gomathi M, et al
    Atranorin from lichens act as potential inhibitor for cervical tumor proteins TGFbeta and kinase enzyme CDK4/CyclinD3: An anti-cancer intervention therapy.
    Int J Biol Macromol. 2025;320.
    

    >> Share

    
    

    
    Int J Cancer

57. JENKINS M, Saidu R, Boa R, Mbatani N, et al
    Performance of thermoablation among women treated for high-risk human papillomavirus in a screen-and-treat program in South Africa.
    Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35519.
    

    >> Share

    
    

    
    Int J Gynaecol Obstet

58. SANTIAGO SANABRIA L, Laverde Cardona VA, Perez D YR, Abreu F, et al
    Barriers in the prevention and early detection of human papillomavirus in Latin America.
    Int J Gynaecol Obstet. 2025;170:1144-1152.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

59. RISHI KS, Harshita K, Spandana P, Donapati PKR, et al
    Clinical outcomes of external radiotherapy boost versus no boost to radiologically positive lymph nodes in FIGO stage IIIC cervical cancer.
    Int J Gynecol Cancer. 2025;35:102030.
    

    >> Share

    
    
60. SUZUKI DA, Gouveia MC, Bonalumi Dos Santos M, Scaranti M, et al
    Beyond survival: reclaiming quality of life after cervical cancer treatment.
    Int J Gynecol Cancer. 2025;35:102026.
    

    >> Share

    
    

    
    Int J Gynecol Pathol

61. SATOSKAR S, Vanderkwaak TJ, Jedrych J, Vang R, et al
    A Trichoadenoma/Trichoepithelioma/Trichoblastoma-like Lesion in the Uterine Cervix Focally Mimics an Adenoid Basal Tumor.
    Int J Gynecol Pathol. 2025;44:466-470.
    

    >> Share

    
    
62. ZYLA RE, Talia KL, Hodgson A
    Entirely Exophytic HPV-associated Endocervical Adenocarcinoma: A Rare But Potentially Aggressive Neoplastic Phenomenon.
    Int J Gynecol Pathol. 2025;44:412-418.
    

    >> Share

    
    

    
    Int J Mol Sci

63. ZAHAN UF, Sohel HI, Nakayama K, Ishikawa M, et al
    A Comparative Analysis of Usual- and Gastric-Type Cervical Adenocarcinoma in a Japanese Population Reveals Distinct Clinicopathological and Molecular Features with Prognostic and Therapeutic Insights.
    Int J Mol Sci. 2025;26:7469.
    

    >> Share

    
    

    
    Int J STD AIDS

64. NYAM CJ, Musa J, Joyce BT, Kim K, et al
    Molecular epidemiology of human papillomavirus genotypes among HIV-negative women and women living with HIV with cervical cancer in two regions in Nigeria.
    Int J STD AIDS. 2025 Aug 17:9564624251362592. doi: 10.1177/09564624251362592.
    

    >> Share

    
    

    
    J Biomed Res

65. ELZEIN IM, Chamseddine A, Eltanboly A, Elzein A, et al
    Cervical cancer perceived risk factors behavior using logistic regression technique.
    J Biomed Res. 2025 Aug 25:1-12. doi: 10.7555/JBR.39.20250047.
    

    >> Share

    
    

    
    J Clin Microbiol

66. GODOY LR, El-Zein M, Padalko E, Verberckmoes B, et al
    Comparative performance of cobas 4800 HPV Test and Anyplex II HPV HR for high-risk human papillomavirus detection.
    J Clin Microbiol. 2025 Jul 9:e0020025. doi: 10.1128/jcm.00200.
    

    >> Share

    
    

    
    J Family Med Prim Care

67. BHARTI A, Hansda R, Bala R, Kumar A, et al
    To determine the diagnostic accuracy of visual inspection of cervix with acetic acid as a screening tool to detect preinvasive cervical cancer - A meta-analysis.
    J Family Med Prim Care. 2025;14:2619-2627.
    

    >> Share

    
    

    
    J Geriatr Oncol

68. KILICOGLU GS, Azak C, Olgun M, Olcay GK, et al
    Treatment outcomes and bone health implications in younger and older patients with locally advanced cervical cancer.
    J Geriatr Oncol. 2025;16:102342.
    

    >> Share

    
    

    
    J Gynecol Oncol

69. WANG CC, Barber EL
    Nodal surgery in early-stage cervical cancer: the PHENIX trial and the road ahead.
    J Gynecol Oncol. 2025 Aug 18. doi: 10.3802/jgo.2025.
    

    >> Share

    
    

    
    J Immunother

70. HAN X, Fang M, Tan H, Wang M, et al
    Clinical Efficacy and Safety of Cadonilimab Immunotherapy in Advanced Cervical Cancer: A Retrospective Study.
    J Immunother. 2025 Aug 21. doi: 10.1097/CJI.0000000000000574.
    

    >> Share

    
    

    
    J Med Screen

71. RICHTER KL, Snyman LC, Dreyer G, Van der Merwe FH, et al
    Aptima HPV E6/E7 mRNA and cytology cross-sectional performance as primary screening tests for detection of high-grade cervical lesions in HIV positive and negative women in South Africa.
    J Med Screen. 2025;32:133-140.
    

    >> Share

    
    

    
    J Med Virol

72. WANG Q, Zhang C, Liu S, Li W, et al
    Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer.
    J Med Virol. 2025;97:e70564.
    

    >> Share

    
    

    
    J Mol Histol

73. ZHANG S, Wang L, Xu SY, Zhang YY, et al
    Role of indoleamine 2,3-Dioxygenase 1 in modulating the malignant biological behavior of cervical cancer cells through the Tryptophan-Kynurenine pathway.
    J Mol Histol. 2025;56:276.
    

    >> Share

    
    

    
    J Natl Cancer Inst

74. TSEGAYE AT, Shing JZ, Vo JB, Kreimer AR, et al
    Racial and ethnic differences in HPV-related cancer incidence in the United States, 2001-2020.
    J Natl Cancer Inst. 2025 Apr 26:djaf107. doi: 10.1093.
    

    >> Share

    
    

    
    J Patient Rep Outcomes

75. ZHU L, Wang Y, Yang S, Li Q, et al
    Patient willingness to pay and preference for cervical cancer treatments among middle- and low-income populations in Xinjiang.
    J Patient Rep Outcomes. 2025;9:107.
    

    >> Share

    
    

    
    J Proteome Res

76. YAN W, Ding B, Yu B, Jin H, et al
    The Multiomics Landscape of Plasma-Derived Small Extracellular Vesicles during the Development of HPV(+) Cervical Cancer.
    J Proteome Res. 2025 Aug 20. doi: 10.1021/acs.jproteome.5c00304.
    

    >> Share

    
    

    
    J Radiat Res

77. OKUMA K, Kiyomatsu T, Takiyama H, Yoshiba A, et al
    Technical report on the first clinical use of a bioabsorbable PGA spacer in HDR brachytherapy for recurrent cervical cancer.
    J Radiat Res. 2025 Aug 22:rraf053. doi: 10.1093.
    

    >> Share

    
    

    
    J Reprod Immunol

78. YOSHIDA M, Nunomura H, Furuta A, Yamada K, et al
    SQSTM1/p62 drives radiosensitivity in cervical cancer via autophagy-independent mechanisms.
    J Reprod Immunol. 2025;171:104633.
    

    >> Share

    
    

    
    JAMA Netw Open

79. YODER AK, Thomas RJ, Huang A, Mandalapu A, et al
    Cervical Cancer Outcomes in Women With HIV in the Age of Antiretroviral Therapy.
    JAMA Netw Open. 2025;8:e2527389.
    

    >> Share

    
    

    
    JMIR Cancer

80. EZECHI OC, Akinsolu FT, Abodunrin OR, Ola OM, et al
    Implementation of Clinical Practice Guidelines to Prevent Cervical Cancer: Mixed Methods Study.
    JMIR Cancer. 2025;11:e68572.
    

    >> Share

    
    

    
    JMIR Hum Factors

81. HAN HR, Lee YJ, Min D, Chepkorir J, et al
    Web-Based Delivery of an Effective Church-Based Intervention Program to Promote Cancer Screening (Community-based Health litEracy-focused intervention for breast and cervical Cancer Control) Among Korean Immigrant Women in the United States: Randomize
    JMIR Hum Factors. 2025;12:e66092.
    

    >> Share

    
    

    
    Lancet

82. MCCORMACK M, Eminowicz G, Vaja S, Hackshaw A, et al
    INTERLACE: not a new standard for cervical cancer chemoradiation - Authors' reply.
    Lancet. 2025;406:807.
    

    >> Share

    
    
83. PETRIC P, Lindegaard JC, Schmid MP, Jurgenliemk-Schulz I, et al
    INTERLACE: not a new standard for cervical cancer chemoradiation.
    Lancet. 2025;406:806-807.
    

    >> Share

    
    

    
    Magn Reson Imaging

84. YANG C, Hassan HA, Omar NF, Soo TH, et al
    The value of multi-parameters MRI based on amide proton transfer imaging in evaluating the efficacy of concurrent radiochemotherapy for locally advanced cervical cancer.
    Magn Reson Imaging. 2025;123:110507.
    

    >> Share

    
    

    
    Mol Cancer

85. ZHOU M, Gao Y, Zhang Y, He L, et al
    CircZFR/YTHDF3 axis drives lymph node metastasis in cervical cancer via FASN translation.
    Mol Cancer. 2025;24:218.
    

    >> Share

    
    

    
    Mol Diagn Ther

86. HELLMAN K, Zupancic M, Jylha C, Tham E, et al
    Human Papillomavirus Type and Viral Load in Relation to Circulating Cell-Free Tumour HPV DNA Level and Survival in Cervical Cancer.
    Mol Diagn Ther. 2025 Aug 16. doi: 10.1007/s40291-025-00809.
    

    >> Share

    
    

    
    N Z Med J

87. FENG S, Mdletshe S
    Recommendations for the use of functional medical imaging in the management of cancer of the cervix in New Zealand: a rapid review.
    N Z Med J. 2025;138:65-84.
    

    >> Share

    
    

    
    Nutrients

88. XU P, Uma Mageswary M, Nisaa AA, Li X, et al
    Antimicrobial and Anticancer Activities of Lactiplantibacillus plantarum Probio87 Isolated from Human Breast Milk.
    Nutrients. 2025;17:2554.
    

    >> Share

    
    

    
    Oncol Nurs Forum

89. GYAN KG, Dunnack Yackel H, Effiong D, Escobar Jones C, et al
    Cervical Cancer Screening Beliefs and Practices Among Black Immigrant Women From Africa and the Caribbean Living in Massachusetts.
    Oncol Nurs Forum. 2025;52:371-381.
    

    >> Share

    
    

    
    Pathol Res Pract

90. YAMADA R, Kawakami F, Maeda N, Nagao S, et al
    Immune cell densities, HLA status, and PD-L1 expression in stage I neuroendocrine neoplasm of the uterine cervix.
    Pathol Res Pract. 2025;273:156146.
    

    >> Share

    
    
91. CHEN Y, Li X, Chen P, Yin Z, et al
    ZNF671 methylation is a potential regression predictor of cervical intraepithelial neoplasia grade 3 in the colposcopy-to-conization interval.
    Pathol Res Pract. 2025;273:156116.
    

    >> Share

    
    

    
    PLoS One

92. KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al
    A scoping review of the levels, implementation strategies, enablers, and barriers to cervical, breast, and colorectal cancer screening among migrant populations in selected English-speaking high-income countries.
    PLoS One. 2025;20:e0329854.
    

    >> Share

    
    

    
    Prev Chronic Dis

93. SABATINO SA, Thompson TD, Croswell JM, Villarroel MA, et al
    Use of Cancer Screening Tests, United States, 2023.
    Prev Chronic Dis. 2025;22:E52.
    

    >> Share

    
    

    
    Radiat Oncol

94. LIANG Y, Yang J, Wei S, Liu Y, et al
    Criteria-calibration approaches to deep learning-based cervical cancer radiation treatment auto-planning.
    Radiat Oncol. 2025;20:131.
    

    >> Share

    
    

    
    Rev Esp Salud Publica

95. ALVAREZ-RODRIGUEZ S, Farinas Cabrero MA, Blanco Gonzalez JM, Fernandez-Feito A, et al
    [Readability, comprehensibility and acceptability of the materials of the Cervical Cancer Population Screening Program in Asturias: a mixed methodology study].
    Rev Esp Salud Publica. 2025;99:e202507040.
    

    >> Share

    
    

    
    Sci Rep

96. AGARWAL M, Kumar M, Dahiya S, Kumar A, et al
    "In silico analysis of human TLR3 missense single nucleotide polymorphisms and their potential association with cancer".
    Sci Rep. 2025;15:30837.
    

    >> Share

    
    
97. PHUNG MT, An PL, Khoja L, Lee AW, et al
    Southern Vietnamese women's views on HPV vaccination, cervical cancer screening, and HPV self-sampling.
    Sci Rep. 2025;15:30928.
    

    >> Share

    
    
98. NAKHARUTAI N, Chitapanarux I, Tharavichitkul E, Traisathit P, et al
    Impact of PM2.5 exposure on acute toxicities and survival outcomes in radiotherapy for cervical cancer.
    Sci Rep. 2025;15:30557.
    

    >> Share

    
    
99. NOVAK EN, Ma A, Kundrod KA, Chang MM, et al
    Extraction-free RT-RPA assay for detection of HPV16, HPV18, and HPV45 mRNA expression.
    Sci Rep. 2025;15:30450.
    

    >> Share

    
    
100. XU Y, Wang J, Chen G
     Analyzing the mechanism of rhubarb in the treatment of cervical cancer based on network pharmacology and molecular docking technology.
     Sci Rep. 2025;15:30027.
     

     >> Share

     
     

     
     Strahlenther Onkol

101. DRAGHINI L, Costantini S, Ippolito E, De Felice F, et al
     Potential prognostic role of the (18)F-FDG PET/CT metabolic response in locally advanced cervical cancer after definitive chemoradiotherapy: a narrative review.
     Strahlenther Onkol. 2025 Aug 19. doi: 10.1007/s00066-025-02452.
     

     >> Share

     
     

     
     Virol J

102. CHEN M, Lhamo Y, Chodron K, Chen L, et al
     High-risk human papillomavirus (hr-HPV) prevalence and abnormal cervical cytology in rural high-altitude communities: a population-based cross-sectional study in the Southern Tibetan Plateau, China (2023-2024).
     Virol J. 2025;22:279.
     

     >> Share

     
     

     
     Zhonghua Zhong Liu Za Zhi

103. GAN JW, Cao DY
     [Progress and clinical application of sentinel lymph node biopsy technique in gynecological malignant tumors].
     Zhonghua Zhong Liu Za Zhi. 2025;47:689-695.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share